Cardiovascular and metabolic benefits of ACE inhibition: moving beyond blood pressure reduction. Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- July 1, 2000
has subject area
- Angiotensin-Converting Enzyme Inhibitors (MeSH)
- Blood Pressure (MeSH)
- Cardiovascular Diseases (MeSH)
- Diabetes Mellitus, Type 2 (MeSH)
- Diabetic Angiopathies (MeSH)
- Humans (MeSH)
- Hypertension (MeSH)
published in
- Diabetes Reviews Journal